Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Moog Inc.

MOGA

FAVORABLE

June 1, 2026

Research Conclusion

At ~$205 (May 2026 estimated), Moog is a quality A&D + medical precision motion control compounder with 9% probability-weighted upside + 0.6% dividend yield and 1.2:1 bull/bear asymmetry. Synthesized fair value $210-$260 (mid $235). The thesis combines long-cycle defense programs with sole-source positions, Space & Defense Controls expansion via constellation + Space Force tailwinds, Medical Devices secular growth from aging demographics + oncology drug delivery, Industrial Systems cycle recovery FY26-27, and operating margin expansion 12% → 14.5% via mix + scale. Recommended stance: Hold/Accumulate for quality A&D sleeves. Reference price at low end of fair value; modest asymmetry; defensive-growth compounder profile suits quality+income portfolios.

Company Overview & Moat Assessment

Moog Inc. (NYSE: MOGA), HQ East Aurora NY, is a precision motion control specialist designing/manufacturing electromechanical, hydraulic, and electrohydraulic actuation systems for defense, space, medical, and industrial markets. Four segments: Aircraft Controls (~47-50% rev), Space & Defense Controls (~13-18%), Industrial Systems (~22-26%), Medical Devices (~10-14%). FY2024 revenue ~$3.4B, adj op margin 12%, adj EBITDA $510M, adj EPS $7.30. Market cap ~$6.6B, net debt ~$700M (1.4x EBITDA). CEO Patrick Roche, CFO Jennifer Walter. US DoD ~45-50% revenue concentration.

▲ Bull Case

  • ◆Space & Defense Controls +15%+/yr from constellation buildout + Space Force scales; potential 26x multiple expansion
  • ◆Operating margin reaches 15% through cost discipline + mix shift toward higher-margin segments; EPS reaches $11.50 by FY28
  • ◆Medical Devices accelerates with oncology + home healthcare growth of +8-10%; mix premium supports valuation expansion

▼ Bear Case

  • ◆DoD budget pressure from continuing resolutions + sequestration risk; revenue growth stalls or contracts
  • ◆Industrial cycle weakness extends in wind + simulation segments; margin compression pressures profitability
  • ◆F-35 production cut 20%+; single-program concentration risk; aftermarket cannot offset volume loss
Primary Debate on Wall Street

“The Street debate centers on whether MOGA's margin expansion path is achievable through an extended industrial cycle. Bull frame: Space + Medical secular tailwinds + cost discipline + long-cycle defense backlog = quality compounder. Bear frame: Industrial drag + DoD budget risk + small-cap liquidity. Sell-side PT $200-$260.”

Top Catalysts
  • ◆Space & Defense quarterly growth acceleration (segment validation)
  • ◆F-35 production rate sustainability (DoD budget signal)
  • ◆Medical Devices segment growth trajectory (+8%+ evidence)
  • ◆Operating margin trajectory progress (12% → 14%+)
  • ◆Backlog growth and order visibility expansion
  • ◆US DoD FY budget appropriations and continuing resolutions
  • ◆Industrial Systems cycle recovery inflection (wind + simulation rebound)
Top Risks
  • ◆DoD budget pressure and sequestration (primary thesis risk)
  • ◆Industrial cycle weakness persists or deepens
  • ◆F-35 production cut 20%+ (single-program concentration)
  • ◆Backlog conversion slowdown or slippage
  • ◆Customer concentration risk (US DoD 45-50% of revenue)
  • ◆Small-cap liquidity constraints and trading volumes
  • ◆Medical Devices competitive intensity increases

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/MOGA/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.

Moog Inc. (MOGA) — Investment Memo | Margin of Insight